This Soleno Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor 6 months ago
NewsDowngradesPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Top Wall Street analysts changed outlook on top names. Check analyst ratings page for complete view. Consider buying SLNO stock, see analysts' views.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Roth Capital analyst Leo Mariani downgraded Magnolia Oil & Gas Corp (NYSE:MGY) from Buy to Neutral and raised the price target from $29 to $32. Magnolia Oil & Gas shares closed at $31.93 on Tuesday. See how other analysts view this stock.
- BTIG analyst Andre Madrid downgraded AIRO Group Holdings Inc (NASDAQ:AIRO) from Buy to Neutral. AIRO Group shares closed at $8.74 on Tuesday. See how other analysts view this stock.
- Roth Capital analyst Leo Mariani downgraded SM Energy Co (NYSE:SM) from Buy to Neutral and raised the price target from $24 to $33. SM Energy shares closed at $31.35 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Raghuram Selvaraju downgraded Soleno Therapeutics Inc (NASDAQ:SLNO) from Buy to Neutral and lowered the price target from $100 to $53. Soleno Therapeutics shares closed at $52.35 on Tuesday. See how other analysts view this stock.
- Roth Capital analyst Leo Mariani downgraded Matador Resources Co (NYSE:MTDR) from Buy to Neutral and increased the price target from $52 to $65. Matador Resources shares closed at $64.49 on Tuesday. See how other analysts view this stock.
Considering buying SLNO stock? Here’s what analysts think:
Photo via Shutterstock